Juul Used Social Media To Target Under-aged Middle School and High School Teens

Juul deliberately created the epidemic of vaping and teens are now getting sick and dying as a result

Friday, October 4, 2019 - An entirely new generation of teenage smokers has been created by the e-cigarette, contrary to the stated objectives of Juul, the nation's largest manufacturer of the device. Juul's CEO has testified that the company's mission statement is to help smokers wean themselves from nicotine delivered by traditional cigarettes to nicotine delivered electronically, controlled and then gradually reduced. Juul's stated objective is to end cigarettes, but that may be misleading as the company's advertising and sponsorships have targeted teens from the very beginning, not adult smokers, on the new age social media advertising platforms of Facebook, Instagram, and YouTube. As a result, millions of teenagers around the world have been enticed to take up the habit of "vaping". Mother Earth News writes about a study conducted by researchers at Stanford University that not only confirms this but also points to Juul's self-incriminating efforts to delete their social media history. According to Mother Earth News: "Until very recently, when the vaping backlash forced them to change, Juul was marketed almost exclusively toward teens using methods and sophistication straight out of the cigarette playbook." JUUL Vape pen lawyers are now offering free case reviews to persons who have suffered from JUUL problems or child nicotine addiction from vaping.

The researchers at Stanford shed light on exactly how Juul operated under the radar of Television and print advertising and went directly to their intended target market. Researchers found that "Advertising prominently featured sweet and fruity flavors, especially mango. The company employed social media influencers as brand ambassadors. They also sought individuals who were popular on the internet, enrolled them in JUUL's affiliate program, and compensated them for posting positive reviews while insisting that they not reveal this relationship. The report concluded that "JUUL's advertising imagery in its first 6 months on the market was patently youth-oriented."

E-cigarettes resemble a computer's portable USB hard drive and are plugged into the USB port to charge its battery. E-cigarettes cost around $50 and require the user to buy flavor pods for $15. Each pod has the same amount of nicotine as a pack of cigarettes.

Instead of helping adult smokers fight their nicotine addiction, e-cigarettes have encouraged middle and high school kids to take up the "vaping" habit, introducing them to smoking and addicted to nicotine. Juul makes it clear on their website that the product contains nicotine and that nicotine is an addictive substance. That makes sense to an adult but has little meaning to teenagers looking for something cool to do. Juul advertising, in fact, targets children, according to the FDA with their advertising of many different flavors. The Food and Drug Administration (FDA) recently sent Juul a warning letter that it had violated the law and illegally marketed its e-cigarettes as being less harmful than tobacco cigarettes. FDA Commissioner Dr. Ned Sharpless said in a statement "regardless of where products like e-cigarettes fall on the continuum of tobacco product risk, the law is clear that, before marketing tobacco products for reduced risk, companies must demonstrate with scientific evidence that their specific product does, in fact, pose less risk or is less harmful."

More Recent JUUL Vape Pen Lawsuit News:

Lawyers for JUUL Vape Pen Lawsuits

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The firm has represented thousands of persons in these and other products liability litigation, including DePuy hip replacement systems, which settled for $2.5 billion and Pradaxa internal bleeding, which settled for $650 million. The Onder Law Firm won over $300 million in four talcum powder ovarian cancer lawsuits in St. Louis to date and other law firms throughout the nation often seek its experience and expertise on complex litigation.